| Receptor-independent cardiac protein kinase Calpha activation by calpain-mediated truncation of regulatory domains. | |
| | |
MedLine Citation:
|
PMID: 20689063 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
RATIONALE: Protein kinase (PK)Cs and calpain cysteine proteases are highly expressed in myocardium. Ischemia produces calcium overload that activates calpains and conventional PKCs. However, calpains can proteolytically process PKCs, and the potential in vivo consequences of this interaction are unknown. OBJECTIVE: To determine the biochemical and pathophysiological consequences of calpain-mediated cardiac PKCα proteolysis. METHODS AND RESULTS: Isolated mouse hearts subjected to global ischemia/reperfusion demonstrated cleavage of PKCα. Calpain 1 overexpression was not sufficient to produce PKCα cleavage in normal hearts, but ischemia-induced myocardial PKCα cleavage and myocardial injury were greatly increased by cardiac-specific expression of calpain 1. In contrast, calpain 1 gene ablation or inhibition with calpastatin prevented ischemia/reperfusion induced PKCα cleavage; infarct size was decreased and ventricular function enhanced in infarcted calpain 1 knockout hearts. To determine consequences of PKCα fragmentation on myocardial protein phosphorylation, transgenic mice were created conditionally expressing full-length PKCα or its N-terminal and C-terminal calpain 1 cleavage fragments. Two-dimensional mapping of ventricular protein extracts showed a distinct PKCα phosphorylation profile that was exaggerated and distorted in hearts expressing the PKCα C-terminal fragment. MALDI mass spectroscopy revealed hyperphosphorylation of myosin-binding protein C and phosphorylation of atypical substrates by the PKCα C-terminal fragment. Expression of parent PKCα produced a mild cardiomyopathy, whereas myocardial expression of the C-terminal PKCα fragment induced a disproportionately severe, rapidly lethal cardiomyopathy. CONCLUSIONS: Proteolytic processing of PKCα by calcium-activated calpain activates pathological cardiac signaling through generation of an unregulated and/or mistargeted kinase. Production of the PKCα C-terminal fragment in ischemic hearts occurs via a receptor-independent mechanism. |
| | |
Authors:
|
Min-Young Kang; Yan Zhang; Scot J Matkovich; Abhinav Diwan; Athar H Chishti; Gerald W Dorn |
Related Documents
:
|
11211163 - There is no effect on remodeling of vascular wall 4 weeks after local delivery of antit... 18503113 - Reperfusion injury and inflammatory responses following acute lower limb revascularizat... 22015133 - "mother and child technique" combined with super selective pharmacological intervention... |
Publication Detail:
|
Type: Journal Article; Research Support, N.I.H., Extramural Date: 2010-08-05 |
Journal Detail:
|
Title: Circulation research Volume: 107 ISSN: 1524-4571 ISO Abbreviation: Circ. Res. Publication Date: 2010 Oct |
Date Detail:
|
Created Date: 2010-10-01 Completed Date: 2010-10-22 Revised Date: 2012-05-07 |
Medline Journal Info:
|
Nlm Unique ID: 0047103 Medline TA: Circ Res Country: United States |
Other Details:
|
Languages: eng Pagination: 903-12 Citation Subset: IM |
Affiliation:
|
Washington University Center for Pharmacogenomics, St Louis, MO 63110, USA. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Animals Calcium / metabolism Calpain / metabolism* Cardiomyopathies / metabolism*, pathology Carrier Proteins / metabolism Humans Mice Mice, Transgenic Myocardial Infarction / metabolism, pathology Myocardial Reperfusion Injury / metabolism*, pathology Myocardium / metabolism*, pathology Phosphorylation / physiology Protein Kinase C-alpha / chemistry, genetics, metabolism* Protein Structure, Tertiary Protein-Serine-Threonine Kinases / chemistry, genetics, metabolism Signal Transduction / physiology |
| Grant Support | |
ID/Acronym/Agency:
|
HL059888/HL/NHLBI NIH HHS; HL080008/HL/NHLBI NIH HHS; HL089517/HL/NHLBI NIH HHS; R01 HL059888-01A1/HL/NHLBI NIH HHS; R01 HL059888-02/HL/NHLBI NIH HHS; R01 HL059888-03/HL/NHLBI NIH HHS; R01 HL059888-04/HL/NHLBI NIH HHS; R01 HL059888-05/HL/NHLBI NIH HHS; R01 HL059888-06/HL/NHLBI NIH HHS; R01 HL059888-07/HL/NHLBI NIH HHS; R01 HL059888-08/HL/NHLBI NIH HHS; R01 HL059888-09A1/HL/NHLBI NIH HHS; R01 HL059888-09A1W1/HL/NHLBI NIH HHS; R01 HL059888-10/HL/NHLBI NIH HHS; R01 HL059888-11/HL/NHLBI NIH HHS; R01 HL059888-12/HL/NHLBI NIH HHS; R01 HL059888-13/HL/NHLBI NIH HHS; R01 HL080008-01A1/HL/NHLBI NIH HHS; R01 HL080008-02/HL/NHLBI NIH HHS; R01 HL080008-03/HL/NHLBI NIH HHS; R01 HL080008-04/HL/NHLBI NIH HHS; R01 HL080008-05/HL/NHLBI NIH HHS; R01 HL080008-06/HL/NHLBI NIH HHS; R01 HL087871-01/HL/NHLBI NIH HHS; R01 HL087871-02/HL/NHLBI NIH HHS; R01 HL087871-03/HL/NHLBI NIH HHS; R01 HL087871-04/HL/NHLBI NIH HHS; R01 HL087871-05/HL/NHLBI NIH HHS; R01 HL087871-06/HL/NHLBI NIH HHS; RC2 HL102222-01/HL/NHLBI NIH HHS; RC2 HL102222-02/HL/NHLBI NIH HHS |
| Chemical | |
Reg. No./Substance:
|
0/Capn1 protein, mouse; 0/Carrier Proteins; 0/myosin-binding protein C; 7440-70-2/Calcium; EC 2.7.11.1/Protein-Serine-Threonine Kinases; EC 2.7.11.13/Protein Kinase C-alpha; EC 3.4.22.-/Calpain |
| Comments/Corrections | |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Involvement of the brain (pro)renin receptor in cardiovascular homeostasis.
Next Document: Notch3 is critical for proper angiogenesis and mural cell investment.